Gaming For Attention: FDA Grants De Novo For Novel ADHD Treatment
Akili Interactive’s EndeavorRx has opened the door for other digital therapies to get to market faster
A new video game pediatric ADHD treatment has opened the door for other such novel therapies to come to market using the less stringent 510(k) pathway, as interest in such products have gained significant steam over the past few years.
You may also be interested in...
Tali’s video game assesses and improves attention in children three to eight years old. Akili markets the EndeavorRx prescription video game therapy to improve attention function in children ages eight to 12. The deal will help Tali commercialize its technology in the US.
The concept of a parent company with operating subsidiaries is becoming increasing common in biotech. The first to do it, Daphne Zohar, who co-founded PureTech back in 2005, tells Scrip how the company has made that model work.
Akili Interactive, Hello Heart and Noom announced new funding rounds today, proving that investors’ strong appetite for companies that are part of the digital transformation in health care.